A Randomized Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions.
Phase of Trial: Phase III
Latest Information Update: 22 Jun 2011
At a glance
- Drugs Sirolimus; Zotarolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Registrational; Therapeutic Use
- Acronyms ENDEAVOR-III
- 18 Apr 2011 Actual trial end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 18 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Apr 2010 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History